Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.


Journal

Gut
ISSN: 1468-3288
Titre abrégé: Gut
Pays: England
ID NLM: 2985108R

Informations de publication

Date de publication:
01 2020
Historique:
received: 23 10 2018
revised: 21 02 2019
accepted: 19 03 2019
pubmed: 21 4 2019
medline: 18 12 2019
entrez: 21 4 2019
Statut: ppublish

Résumé

Patients with primary sclerosing cholangitis (PSC) were previously shown to display a bacterial gut dysbiosis but fungal microbiota has never been examined in these patients. The aim of this study was to assess the fungal gut microbiota in patients with PSC. We analysed the faecal microbiota of patients with PSC and concomitant IBD (n=27), patients with PSC and no IBD (n=22), patients with IBD and no PSC (n=33) and healthy subjects (n=30). Bacterial and fungal composition of the faecal microbiota was determined using 16S and ITS2 sequencing, respectively. We found that patients with PSC harboured bacterial dysbiosis characterised by a decreased biodiversity, an altered composition and a decreased correlation network density. These alterations of the microbiota were associated with PSC, independently of IBD status. For the first time, we showed that patients with PSC displayed a fungal gut dysbiosis, characterised by a relative increase in biodiversity and an altered composition. Notably, we observed an increased proportion of This study demonstrates that bacteria and fungi contribute to gut dysbiosis in PSC.

Identifiants

pubmed: 31003979
pii: gutjnl-2018-317791
doi: 10.1136/gutjnl-2018-317791
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-102

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Sara Lemoinne (S)

Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, INSERM, Paris, France.
Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne Université, INSERM, Paris, France.
Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Astrid Kemgang (A)

Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, INSERM, Paris, France.
Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne Université, INSERM, Paris, France.
Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Karima Ben Belkacem (K)

Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, INSERM, Paris, France.
Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne Université, INSERM, Paris, France.
Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Marjolène Straube (M)

Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, INSERM, Paris, France.
Department of Gastroenterology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Sarah Jegou (S)

Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, INSERM, Paris, France.
Department of Gastroenterology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Christophe Corpechot (C)

Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, INSERM, Paris, France.
Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne Université, INSERM, Paris, France.
Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Olivier Chazouillères (O)

Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, INSERM, Paris, France.
Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne Université, INSERM, Paris, France.
Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Chantal Housset (C)

Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, INSERM, Paris, France.
Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne Université, INSERM, Paris, France.
Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Harry Sokol (H)

Centre de Recherche Saint-Antoine (CRSA), Sorbonne Université, INSERM, Paris, France.
Department of Gastroenterology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
UMR1319 Micalis, AgroParisTech, INRA, Jouy-en-Josas, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH